Noveris Health Sciences
(OTC) MYCOF
Noveris Health Sciences Financials at a Glance
Market Cap
$1.63M
Revenue (TTM)
$0.00
Net Income (TTM)
$2.29M
EPS (TTM)
$1.33
P/E Ratio
0.99
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.32
Volume
8
Open
$1.34
Price
$1.32
Volume
8
Open
$1.34
Previous Close
$1.32
Daily Range
$1.13 - $1.40
52-Week Range
$0.01 - $1.40
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.32
Volume
8
Open
$1.34
Previous Close
$1.32
Daily Range
$1.13 - $1.40
52-Week Range
$0.01 - $1.40
MYCOF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Noveris Health Sciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
3
CEO
David Joshua Bartch
Website
www.mydecine.comHeadquarters
Vancouver, BC V6E 3C9, CA
MYCOF Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
25%
Return on Assets
9452%
Earnings Yield
1.01%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.63M
Shares Outstanding
1.24M
Volume
8
Short Interest
0.00%
Avg. Volume
443.21
Financials (TTM)
Gross Profit
$0.00
Operating Income
$2.49M
EBITDA
$2.48M
Operating Cash Flow
$37.32K
Capital Expenditure
$0.00
Free Cash Flow
$37.32K
Cash & ST Invst.
$325.00
Total Debt
$6.87M
Noveris Health Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$1.63M
N/A
Market Cap/Employee
$542.40K
N/A
Employees
3
N/A
Net Income
$73.79K
+103.7%
EBITDA
$107.70K
+106.7%
Quarterly Fundamentals
Net Cash
$6.90M
-6.6%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$6.94M
+6.3%
Return on Assets
9451.85%
N/A
Return on Invested Capital
25.49%
N/A
Free Cash Flow
$9.60K
-42.3%
Operating Cash Flow
$9.60K
-42.3%